89bio (ETNB)
US Market

89bio (ETNB) Financial Statements


89bio Financial Overview

89bio's market cap is currently ―. The company's EPS TTM is $-1.999; its P/E ratio is -5.52; 89bio is scheduled to report earnings on March 20, 2024, and the estimated EPS forecast is $-0.49. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue----$ 0.00
Gross Profit-----
EBIT$ -33.77M$ -37.50M$ -26.76M$ -24.83M$ -27.04M
EBITDA$ -35.68M$ -38.46M$ -27.61M$ -25.03M$ -27.02M
Net Income Common Stockholders$ -34.73M$ -38.39M$ -28.84M$ -24.60M$ -26.80M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 251.93M$ 245.44M$ 350.93M$ 55.26M$ 193.34M
Total Assets$ 460.11M$ 492.51M$ 494.24M$ 196.82M$ 200.58M
Total Debt$ 24.87M$ 24.75M$ 24.64M$ 20.05M$ 20.02M
Net Debt$ -227.06M$ -220.69M$ -326.29M$ -35.21M$ -173.32M
Total Liabilities$ 49.90M$ 50.52M$ 48.49M$ 44.99M$ 48.01M
Stockholders Equity$ 410.21M$ 441.99M$ 445.83M$ 151.83M$ 152.57M
Cash Flow-
Free Cash Flow$ -30.36M$ -34.45M$ -30.09M-$ -14.81M
Operating Cash Flow$ -30.36M$ -34.45M$ -30.09M-$ -14.81M
Investing Cash Flow$ 38.33M$ -101.81M$ 4.11M-$ -42.06M
Financing Cash Flow$ -1.48M$ 30.77M$ 321.65M-$ 68.63M
Currency in USD

89bio Earnings and Revenue History

89bio Debt to Assets

89bio Cash Flow

89bio Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis